0.000USD0.000Pre-market 08/03, 09:30 (ET)
857.31MMarket Cap
5.23P/E TTM
ABUS Balance Sheet
You can check out the annual or quarterly balance sheets of Arbutus Biopharma Corp here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing ABUS stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Arbutus Biopharma Corp Have?
In its most recent quarterly, Arbutus Biopharma Corp had 23.71M in cash and cash equivalents.
How Much Are Arbutus Biopharma Corp's Total Liabilities?
Arbutus Biopharma Corp reported 18.04M in total liabilities as of the latest reported quarter, including 6.01M in current liabilities and 12.04M in non-current liabilities.
What Are Arbutus Biopharma Corp's Total Assets?
As of the latest reported quarter, Arbutus Biopharma Corp's total assets were 94.62M, consisting of 94.46M in current assets and 162.00K in non-current assets.
How Much Shareholders' Equity Does Arbutus Biopharma Corp Have?
Arbutus Biopharma Corp reported 76.58M in total shareholders' equity as of the latest reported quarter.